Funded startups/Niche Biopharmaceuticals LLC
NB

Niche Biopharmaceuticals LLC

SEC filing
Pharmaceuticals · Shorewood, MN
Form D on EDGAR
Amount raised$200Ksold at filing
Total offering$200K
Investors in the raise4count reported to the SEC
FiledMay 11, 2026first sale Apr 20, 2026

Form D does not name the investors. If a news report names them, they appear here.

Named in the filing

Daniel SaccaniDirector
Patrick SchlievertDirector
Robert KlemDirector
Dayton ReardanExecutive Officer, Director, Promoter
Paul BrennanDirector

Executive officers, directors and promoters as listed on the Form D.

Filing history

FormFiledAmount soldOffering
DMay 11, 2026$200K$200KEDGAR
DMay 9, 2025$100K$100KEDGAR